SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001571049-16-013792
Filing Date
2016-04-11
Accepted
2016-04-11 17:23:56
Documents
5
Period of Report
2016-05-26
Effectiveness Date
2016-04-11

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT t1600915-def14a.htm DEF 14A 527927
2 GRAPHIC t1600915_pc1.jpg GRAPHIC 940819
3 GRAPHIC t1600915_pc2.jpg GRAPHIC 781539
4 GRAPHIC t1600915_pc3.jpg GRAPHIC 777613
5 GRAPHIC t1600915_pc4.jpg GRAPHIC 661458
  Complete submission text file 0001571049-16-013792.txt   4875549
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 161565871
SIC: 2834 Pharmaceutical Preparations